BiopharmaTrend: Where Tech Meets Bio

BioPharmaTrend

#advertisement

12th Aging Research & Drug Discovery Meeting

Latest News

Japan’s Elix Launches AI Drug Discovery Platform …

Japan’s Elix Launches AI Drug Discovery Platform Trained on Confidential Pharma Data via Federated Learning

Tokyo-based Elix (founded 2016) has launched Elix Discovery, an AI drug discovery platform powered by federated learning models trained on proprietary compound data from 16 … Read More

Google Expands MedGemma Collection With Multimodal Health …

Google Expands MedGemma Collection With Multimodal Health AI Models for Open Development

Google Research has released two new models—MedGemma 27B Multimodal and MedSigLIP—as part of its open-source Health AI Developer Foundations (HAI-DEF) initiative, expanding the MedGemma suite … Read More

Xaira Therapeutics Appoints Biotech Exec Behind Belharra …

Xaira Therapeutics Appoints Biotech Exec Behind Belharra and Ambys as President and COO to Scale AI-Driven Drug Discovery Platform

Xaira Therapeutics, the AI-native biotech launched in 2024 with over $1 billion in funding, has appointed biotech executive Jeff Jonker as President and Chief Operating … Read More

NIH To End Funding for Animal-Only Studies, Backing Shift to New Approach Methodologies

datma Launches Free Tool for Pharma to Assess Biomarker Coverage in Federated RWD

AbbVie Acquires Capstan Therapeutics for $2.1B, Gaining In Vivo CAR-T Platform Targeting Autoimmune Diseases

Chai Discovery Releases All-Atom Foundation Model for Zero-Shot Antibody Design with 16–20% Hit Rates

Arc Institute Opens Virtual Cell Challenge With $175K in AI Benchmarking Prizes

SandboxAQ Releases Public Database Containing 5.2 Million Synthetic Protein-Ligand Structures

Read latest news ›››

Latest Insights

How AI, Graphs, and GraphRAG Are Set …

by Dominik Tomicevic

How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment

An estimated 6.9 million Americans aged 65 and older are living with Alzheimer’s. Without major medical breakthroughs, that number is projected to rise to 13.8 … Read More

AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis

by Adele Ruder, Alexander Hustinx, Louise von Stechow

AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis

Rare diseases, which affect more than 300 million people worldwide, are often difficult to diagnose. Many patients wait five years or more for a correct … Read More

Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome

by Louise von Stechow

AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis

by Adele Ruder, Alexander Hustinx, Louise von Stechow

How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment

by Dominik Tomicevic

Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific

by BiopharmaTrend

Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research

by BiopharmaTrend

AI in Drug Safety: From Concept to Reality, The Industry's Path Forward

by Dr. Karthik Muthusamy

Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development

by Bea Mann, PhD

Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?

by Andreas Dreps, Bea Mann, PhD

Read all insights ›››

From Our Partners

Read All ›››

This AI Startup Joins Forces With NVIDIA's …

Sponsored by RECEPTOR.AI

This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery

Navigating the Crossroads of AI and Oncology: …

Sponsored by Lantern Pharma

Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma

Unlocking Interoperability with AI: How This Company …

Sponsored by Trialize

Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs …

Sponsored by MEDSIR

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology

Partner Events

View all events ›››

22nd BioPharma Drug Discovery Nexus Conference Belgium

22nd BioPharma Drug Discovery Nexus Conference Belgium

Event Date: April 29, 2026 - April 29, 2026

Location: Belgium (Brussels, Holiday Inn)

Website: Link

The 12th Aging Research & Drug Discovery Meeting

The 12th Aging Research & Drug Discovery Meeting

Event Date: Aug. 25, 2025 - Aug. 29, 2025

Location: Denmark (Ceremonial Hall, University of Copenhagen)

Website: Link

Interactive Response Technologies 2025

Interactive Response Technologies 2025

Event Date: Oct. 14, 2025 - Oct. 15, 2025

Location: United States of America (The Westin Copley Place, Boston, MA)

Website: Link

RNA Leaders USA Congress

RNA Leaders USA Congress

Event Date: Sept. 10, 2025 - Sept. 11, 2025

Location: United States of America (Boston Exhibition & Convention Center)

Website: Link

Case Studies

Read All ›››

Revolutionizing Clinical Trials: How AI and Automation …

Sponsored by Trialize

Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days

Busting the PoseBusters v3: AI Docking Software …

Sponsored by RECEPTOR.AI

Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy

Using End-to-End Wet Lab Automation Combined with …

Sponsored by Arctoris

Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery

Cyclica's Chemical Probes for DCAF1

Sponsored by Cyclica

Cyclica's Chemical Probes for DCAF1

Application of AI-driven Xanthos Platform for Designing …

Sponsored by Celeris Therapeutics

Application of AI-driven Xanthos Platform for Designing Protein Degraders

QUAISAR Computational Platform for Designing Targeted Protein …

Sponsored by Roivant Sciences

QUAISAR Computational Platform for Designing Targeted Protein Degraders

AI Becomes a Drop-in Replacement for Docking

Sponsored by RECEPTOR.AI

AI Becomes a Drop-in Replacement for Docking

Powering Cancer Drug Discovery and Development Using …

Sponsored by Lantern Pharma

Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®

Interviews

Read All ›››

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs …

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology

Dr. James Field on Breaking the 'Cognition …

Dr. James Field on Breaking the 'Cognition Barrier' in Antibody Discovery with AI and Robotics

Rethinking Clinical Trials: Tim Smith on Medable’s …

Rethinking Clinical Trials: Tim Smith on Medable’s Approach to Speed and Efficiency

Navigating the Crossroads of AI and Oncology: …

Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma

Most Read

Hunting Cancer Before It Can Hunt You: …

Hunting Cancer Before It Can Hunt You: A Bird's Eye View of Cell-Free DNA Market Trends

AI Drug Discovery: Key Trends and Developments …

AI Drug Discovery: Key Trends and Developments in Pharmaceutical Industry

7 Promising RNA Biotech Companies To Watch …

7 Promising RNA Biotech Companies To Watch in 2024

How AI Empowers Biomarker-Driven Clinical Trials

How AI Empowers Biomarker-Driven Clinical Trials